Calza A M, Schmied E, Harms M
Clinique de Dermatologie, Hôpital Cantonal Universitaire, Genève, Suisse.
Dermatology. 1992;184(4):314-6. doi: 10.1159/000247582.
We review the use of corticosteroids in preventing postherpetic neuralgia (PHN) in a retrospective study over 5 years and 10 months. Out of 113 patients evaluable, 46 (40%) had PHN. 21 of these 46 patients (38%) had received prednisone (p = 0.49; n.s.). Duration and intensity of PHN were not different in the prednisone-treated group. This long-term study does not support the use of prednisone for preventing PHN.
我们在一项为期5年零10个月的回顾性研究中，对皮质类固醇预防带状疱疹后神经痛（PHN）的使用情况进行了评估。在113例可评估患者中，46例（40%）发生了PHN。这46例患者中有21例（38%）接受过泼尼松治疗（p = 0.49；无统计学意义）。泼尼松治疗组的PHN持续时间和强度并无差异。这项长期研究并不支持使用泼尼松预防PHN。
